Atlas Trials

Mesenchymal Stem Cell Therapy for SARS-CoV-2-related Acute Respiratory Distress Syndrome

Clinical trial NCT04366063 · UNKNOWN

Trial details

NCT number
NCT04366063
Sponsor
Royan Institute
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Covid-19
Start date
2020-04-05
Primary completion
2020-06-06
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.